Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-000294-24Phase 4Terminated
Phase 4 trial of bupivacaine in postoperative pain, sponsored by Aarhus University Hospital. Primary endpoint: Cumulated opioid usage 48 h postoperatively. Started Jun 2020; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-000294-24.